This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Wall Street Analysts See a 27.1% Upside in Freshpet (FRPT): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Freshpet (FRPT) points to a 27.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks.com featured highlights Freshpet, OptimizeRx and Pinterest
by Zacks Equity Research
Freshpet, OptimizeRx and Pinterest have been highlighted in this Screen of The Week article.
4 Grocery Stocks to Boost Your Portfolio on Soaring Sales
by Ritujay Ghosh
Online grocery sales are increasing, helping stocks like The Kraft Heinz Company (KHC), Lamb Weston Holdings, Inc. (LW), Freshpet, Inc. (FRPT) and Vital Farms, Inc. (VITL).
3 Stocks Worth a Buy for Superb Earnings Acceleration
by Tirthankar Chakraborty
Invest in stocks such as Freshpet (FRPT), OptimizeRx (OPRX) and Pinterest (PINS) at the moment for solid earnings acceleration.
Wall Street Analysts Think Freshpet (FRPT) Could Surge 34.47%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 34.5% upside potential for Freshpet (FRPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Earnings Preview: Darling Ingredients (DAR) Q3 Earnings Expected to Decline
by Zacks Equity Research
Darling (DAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Freshpet (FRPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Freshpet (FRPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Freshpet (FRPT) Looks Just Ahead of Q3 Earnings
by Zacks Equity Research
Freshpet's (FRPT) third-quarter 2023 results are likely to reflect gains from the sturdy product offerings, innovation, pricing and distribution initiatives.
Company News for Aug 8, 2023
by Zacks Equity Research
Companies in The News Are: KKR,SAGE,VTRS,FRPT
Freshpet (FRPT) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Freshpet (FRPT) delivered earnings and revenue surprises of 7.89% and 1.30%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Vital Farms (VITL) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 150% and 1.49%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Freshpet (FRPT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Freshpet (FRPT) delivered earnings and revenue surprises of -30% and 0.57%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Darling Ingredients (DAR) Q1 Earnings Expected to Decline
by Zacks Equity Research
Darling (DAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Freshpet (FRPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Freshpet (FRPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Freshpet (FRPT) Soars 6.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Freshpet (FRPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Freshpet (FRPT) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Freshpet (FRPT) delivered earnings and revenue surprises of 25% and 9.76%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's How Freshpet (FRPT) Looks Just Ahead of Q4 Earnings
by Zacks Equity Research
Freshpet's (FRPT) fourth-quarter 2022 results are likely to reflect gains from the sturdy product offerings, innovation, pricing and distribution initiatives.
Nu Skin (NUS) Readies for Q4 Earnings: Everything to Note
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter results are likely to reflect the adverse impacts of cost inflation and currency translations, whereas a focus on the Nu Vision 2025 strategy is likely to have been an upside.
Service Corporation (SCI) Queued for Q4 Earnings: Things to Note
by Zacks Equity Research
Service Corporation's (SCI) fourth-quarter 2022 performance will likely reflect the adverse impact of rising inflationary pressure. Rising corporate general and administrative costs are a concern.
Factors to Watch Ahead of Kraft Heinz's (KHC) Q4 Earnings
by Zacks Equity Research
Kraft Heinz's (KHC) fourth-quarter results are likely to reflect gains from pricing actions and a focus on the operating model amid cost and supply-chain concerns.
Flowers Foods (FLO) Readies for Q4 Earnings: Things to Note
by Zacks Equity Research
Flowers Foods' (FLO) fourth-quarter fiscal 2022 performance will likely reflect gains from pricing efforts. The company remains focused on sustaining its solid momentum via innovation and marketing.
Kellogg (K) Set to Report Q4 Earnings: What Should You Know?
by Zacks Equity Research
Kellogg's (K) fourth-quarter results are likely to reflect strength in the snacks business and emerging markets, whereas cost inflation is likely to have been a concern.
Philip Morris (PM) Set to Report Q4 Earnings: What to Know?
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter performance is likely to have witnessed the impacts of escalated costs, though solid pricing is likely to have been a driver.
Coty (COTY) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Coty's second-quarter fiscal 2023 performance is most likely to reflect the adverse impact of inflationary pressure and supply-chain-related headwinds. Unfavorable currency rates are a concern.
Pilgrim's Pride (PPC) Set to Report Q4 Earnings: Things to Note
by Zacks Equity Research
Pilgrim's Pride's (PPC) fourth-quarter performance is likely to have witnessed an escalated cost of sales.